Depression News and Research RSS Feed - Depression News and Research

Depression is a serious medical illness that involves the brain. It's more than just a feeling of being "down in the dumps" or "blue" for a few days. If you are one of the more than 20 million people in the United States who have depression, the feelings do not go away. They persist and interfere with your everyday life.
Magnesium Flakes named ‘Best Sports’ product

Magnesium Flakes named ‘Best Sports’ product

A pioneering mineral bath soak has scooped the ‘Best Sports’ product accolade at the Natural Lifestyle Product Awards 2015. [More]
Positive bosutinib response for elderly blast phase CML patient

Positive bosutinib response for elderly blast phase CML patient

A case study suggests that the third-generation tyrosine kinase inhibitor bosutinib may be considered as induction therapy for blast phase chronic myeloid leukaemia in older patients. [More]
College students with Problematic Internet Use report positive and negative effects on family relationships

College students with Problematic Internet Use report positive and negative effects on family relationships

College students who are addicted to the Internet report positive and negative effects on their family relationships, according to new research from Georgia State University and the University of North Carolina at Chapel Hill. [More]
IDEAL study holds new hope for children exposed to methamphetamine in the womb

IDEAL study holds new hope for children exposed to methamphetamine in the womb

Despite continuing reports that methamphetamine abuse during pregnancy can lead to behavioral and emotional problems in children, pregnant women continue to abuse the illicit drug. Nearly one-fourth of pregnant women seeking treatment at federal facilities were methamphetamine users. [More]
New brain imaging technique may help identify children at risk of developing depression

New brain imaging technique may help identify children at risk of developing depression

A new brain imaging study from MIT and Harvard Medical School may lead to a screen that could identify children at high risk of developing depression later in life. [More]
People suffering from chronic stress, anxiety may be at increased risk for depression and dementia

People suffering from chronic stress, anxiety may be at increased risk for depression and dementia

A scientific review paper warns that people need to find ways to reduce chronic stress and anxiety in their lives or they may be at increased risk for developing depression and even dementia. [More]
Migraines heat up as women near menopause

Migraines heat up as women near menopause

Migraine headaches heat up as women approach menopause, according to a new study from researchers at the University of Cincinnati, Montefiore Headache Center, Albert Einstein College of Medicine and Vedanta Research. [More]
Childhood abuse and neglect associated with worse executive function in adulthood

Childhood abuse and neglect associated with worse executive function in adulthood

The scars of childhood abuse and neglect affect adults' brains for decades to come - including their ability to process and act on information both quickly and accurately, new research suggests. [More]

Survey provides no evidence that depressive symptoms vary from season to season

A large-scale survey of U.S. adults provides no evidence that levels of depressive symptoms vary from season to season, according to new research published in Clinical Psychological Science, a journal of the Association for Psychological Science. The findings are inconsistent with the notion of seasonal depression as a commonly occurring disorder. [More]
Study provides better understanding of familial risk for depression

Study provides better understanding of familial risk for depression

Building on a 30-year, three-generation study of depressed individuals, their children and offspring, a study published in the journal Psychiatry Research: Neuroimaging provides a better understanding of the familial risk for depression and the role neuroplasticity might have in increasing the risk of developing depression. [More]
Mood disorder experts question effectiveness of metyrapone drug

Mood disorder experts question effectiveness of metyrapone drug

Pioneering research by mood disorder experts at Newcastle University has questioned the effectiveness of metyrapone, a drug suggested to treat depression. [More]
Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

A study published in the Journal of Headache and Pain, carried out by Dr. Thomas Kinfe of the University of Bonn, found that twice daily stimulation of the vagus nerve with the hand-held gammaCore nVNS device reduced the number of headache days per month from 14.7 to 8.9 (p<0.001) and the number of monthly migraine attacks from 7.3 to 4.5 (p<0.001). [More]
Low levels of cortisol in bipolar patients associated with depression, obesity and metabolic syndrome

Low levels of cortisol in bipolar patients associated with depression, obesity and metabolic syndrome

New observations show that older bipolar patients often have decreased activity in the hormone system responsible for the secretion of the stress hormone cortisol. Low levels of cortisol in bipolar patients were also associated with depression, low quality of life, obesity, dyslipidaemia and metabolic syndrome. [More]
Depression in expectant parents during pregnancy increases risk of premature birth

Depression in expectant parents during pregnancy increases risk of premature birth

Depression in both expectant mothers and fathers increases the risk of premature birth, finds a study published in BJOG: an International Journal of Obstetrics and Gynaecology (BJOG). [More]
AASM officially launches new telemedicine system to increase patient access to sleep medicine

AASM officially launches new telemedicine system to increase patient access to sleep medicine

Today the American Academy of Sleep Medicine officially launched AASM Sleep, a new state-of-the-art telemedicine platform that will dramatically increase patient access to the expertise of board-certified sleep medicine physicians and accredited sleep centers. [More]
Simple blood test could help eliminate B12 deficiencies among older adults in long-term care homes

Simple blood test could help eliminate B12 deficiencies among older adults in long-term care homes

A high proportion of older adults entering long-term care homes in Ontario are B12 deficient, with more developing deficiencies over the course of their first year in residence, according to research from the University of Waterloo. There is a connection between B12 deficiency and several serious health conditions. [More]
Study shows slow global progress on stillbirth prevention leaves over 2.6 million babies at risk each year

Study shows slow global progress on stillbirth prevention leaves over 2.6 million babies at risk each year

More than 2.6 million stillbirths continue to occur globally every year with very slow progress made to tackle this 'silent problem', according to new research published in The Lancet. Despite significant reductions in the number of maternal and child deaths, there has been little change in the number of stillbirths (in the third trimester of pregnancy) even though the majority are preventable. [More]
Anticholinesterase offers a ‘steadying hand’ to PD patients

Anticholinesterase offers a ‘steadying hand’ to PD patients

The dementia drug rivastigmine may reduce the risk of falls in patients with Parkinson’s disease by improving gait stability, findings from the phase II ReSponD trial show. [More]
Citalopram of limited use for dementia-associated agitation

Citalopram of limited use for dementia-associated agitation

The use of citalopram for the treatment of agitation in Alzheimer’s disease may be limited to a small group of people with moderate agitation and low levels of cognitive impairment, study findings suggest. [More]
Rapastinel demonstrates pro-cognitive benefits in animal model of cognitive impairment

Rapastinel demonstrates pro-cognitive benefits in animal model of cognitive impairment

Allergan plc, a leading global pharmaceutical company, announced today that new data on the investigational medication rapastinel (GLYX-13) and its lack of impairment on cognitive function were published in the peer-reviewed journal Behavioural Brain Research. [More]
Advertisement
Advertisement